Articles dans des revues avec comité de lecture (262)

  1. 121. Gottesfeld, J. M., & Pandolfo, M. (2009). Development of histone deacetylase inhibitors as therapeutics for neurological disease. Future neurology, 4, 775-784.
  2. 122. Bousser, M., Amarenco, P., Chamorro, A., Fisher, M., Ford, I., Fox, K., Hennerici, M., Mattle, H., Rothwell, P., PERFORM Study Investigators,, & Pandolfo, M. (2009). Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study. Cerebrovascular diseases, 27(5), 509-518. doi:10.1159/000212671
  3. 123. Goole, J., Van Gansbeke, B., Pilcer, G., Deleuze, P., Blocklet, D., Goldman, S., Pandolfo, M., Vanderbist, F., & Amighi, K. (2008). Pharmacoscintigraphic and pharmacokinetic evaluation on healthy human volunteers of sustained-release floating minitablets containing levodopa and carbidopa. International journal of pharmaceutics, 364(1), 54-63. doi:10.1016/j.ijpharm.2008.08.016
  4. 124. Pandolfo, M. (2008). Friedreich ataxia. Archives of neurology, 65(10), 1296-1303. doi:10.1001/archneur.65.10.1296
  5. 125. Diener, H.-C., Sacco, R. L., Yusuf, S., Cotton, D., Ounpuu, S., Lawton, W. A., Palesch, Y., Martin, R., Albers, G. W., Bath, P., Bornstein, N., Chan, B. P., Chen, S.-T., Cunha, L., Dahlöf, B., De Keyser, J., Donnan, G. A., Estol, C., Gorelick, P., Gu, V., Hermansson, K., Hilbrich, L., Kaste, M., Lu, C., Machnig, T., Pais, P., Roberts, R., Skvortsova, V., Teal, P., Toni, D., VanderMaelen, C., Voigt, T., Weber, M., Yoon, B.-W., Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group,, & Pandolfo, M. (2008). Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet neurology, 7(10), 875-884. doi:10.1016/S1474-4422(08)70198-4
  6. 126. Schmitz-Hübsch, T., Coudert, M., Bauer, P., Giunti, P., Globas, C., Baliko, L., Filla, A., Mariotti, C., Rakowicz, M., Charles, P., Ribai, P., Szymanski, S., Infante, J., van de Warrenburg, B. P., Dürr, A., Timmann, D., Boesch, S., Fancellu, R., Rola, R., Depondt, C., Schöls, L., Zdienicka, E., Kang, J.-S., Döhlinger, S., Kremer, B., Stephenson, D. A., Melegh, B., Pandolfo, M., di Donato, S., du Montcel, S. T., & Klockgether, T. (2008). Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology, 71(13), 982-989. doi:10.1212/01.wnl.0000325057.33666.72
  7. 127. Yusuf, S., Diener, H.-C., Sacco, R. L., Cotton, D., Ounpuu, S., Lawton, W. A., Palesch, Y., Martin, R., Albers, G. W., Bath, P., Bornstein, N., Chan, B. P., Chen, S.-T., Cunha, L., Dahlöf, B., De Keyser, J., Donnan, G. A., Estol, C., Gorelick, P., Gu, V., Hermansson, K., Hilbrich, L., Kaste, M., Lu, C., Machnig, T., Pais, P., Roberts, R., Skvortsova, V., Teal, P., Toni, D., VanderMaelen, C., Voigt, T., Weber, M., Yoon, B.-W., PRoFESS Study Group,, & Pandolfo, M. (2008). Telmisartan to prevent recurrent stroke and cardiovascular events. The New England journal of medicine, 359(12), 1225-1237. doi:10.1056/NEJMoa0804593
  8. 128. Sacco, R. L., Diener, H.-C., Yusuf, S., Cotton, D., Ounpuu, S., Lawton, W. A., Palesch, Y., Martin, R., Albers, G. W., Bath, P., Bornstein, N., Chan, B. P., Chen, S.-T., Cunha, L., Dahlöf, B., De Keyser, J., Donnan, G. A., Estol, C., Gorelick, P., Gu, V., Hermansson, K., Hilbrich, L., Kaste, M., Lu, C., Machnig, T., Pais, P., Roberts, R., Skvortsova, V., Teal, P., Toni, D., VanderMaelen, C., Voigt, T., Weber, M., Yoon, B.-W., PRoFESS Study Group,, & Pandolfo, M. (2008). Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. The New England journal of medicine, 359(12), 1238-1251. doi:10.1056/NEJMoa0805002
  9. 129. Abboud, S., Viiri, L. E., Lütjohann, D., Goebeler, S., Luoto, T., Friedrichs, S., Desfontaines, P., Gazagnes, M.-D., Laloux, P., Peeters, A., Seeldrayers, P., Lehtimaki, T., Karhunen, P. J., Pandolfo, M., & Laaksonen, R. (2008). Associations of apolipoprotein E gene with ischemic stroke and intracranial atherosclerosis. European journal of human genetics, 16(8), 955-960. doi:10.1038/ejhg.2008.27
  10. 130. Pandolfo, M. (2008). Drug Insight: antioxidant therapy in inherited ataxias. Nature clinical practice. Neurology, 4(2), 86-96. doi:10.1038/ncpneuro0704
  11. 131. McNeill, A., Pandolfo, M., Kuhn, J., Shang, H., & Miyajima, H. (2008). The neurological presentation of ceruloplasmin gene mutations. European neurology, 60(4), 200-205. doi:10.1159/000148691
  12. 132. Rai, M., Soragni, E., Jenssen, K., Burnett, R., Herman, D., Coppola, G., Geschwind, D. H., Gottesfeld, J. M., & Pandolfo, M. (2008). HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model. PloS one, 3(4), e1958. doi:10.1371/journal.pone.0001958

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Suivant >>